TITLE:
A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

CONDITION:
Major Depressive Disorder

INTERVENTION:
Antidepressant + Placebo

SUMMARY:

      This trial is a 14 week, randomized, double-blind, placebo controlled study, to assess the
      safety and efficacy of aripiprazole as adjunctive treatment to an ongoing antidepressant
      treatment in patients with Major Depressive Disorder.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        Inclusion Criteria:

          -  Men and women, 18-65 years old

          -  Experienced a Major Depressive Disorder with the current episode of minimally 8 weeks
             in duration.

          -  Treatment history of an inadequate response to at least one and no more than three
             antidepressants.
      
